The BioFlash® system is based on the CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) technology, a revolutionary diagnostic technology developed by the scientists at Massachusetts Institute of Technology and published in Science. BioFlash® delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity. Accurate results can be obtained in less than 3 minutes by non-expert users.
CANARY® incorporates pathogen-specific antibodies expressed on a biosensor surface that, in the presence of a pathogen (virus, bacteria or toxin), trigger an intracellular calcium release that in-turn activates bioluminescent proteins to generate the emission of light.
Play the video below for a detailed illustration of CANARY Signal Amplification: